Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 500 | $0.05 | $22.50 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 20 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,333,367 Read SEC document |
| September 16, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.05 | $225.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 19 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,333,867 Read SEC document |
| September 16, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.04 | $200.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 18 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,338,867 Read SEC document |
| September 14, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $400.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 17 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,343,867 Read SEC document |
| August 11, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.08 | $800.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 16 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,353,867 Read SEC document |
| August 10, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 15,000 | $0.08 | $1,200.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 15 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,363,867 Read SEC document |
| August 10, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.08 | $375.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 14 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,378,867 Read SEC document |
| August 06, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 4,560 | $0.08 | $342.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 13 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,383,867 Read SEC document |
| August 05, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 600 | $0.07 | $39.60 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 12 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,388,427 Read SEC document |
| August 03, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.08 | $800.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 11 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,389,027 Read SEC document |
| August 03, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 1,224 | $0.08 | $101.59 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 10 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,399,027 Read SEC document |
| August 02, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,500 | $0.08 | $423.50 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 9 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,400,251 Read SEC document |
| August 02, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.08 | $390.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 8 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,405,751 Read SEC document |
| July 02, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 500 | $0.09 | $42.50 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 7 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,410,751 Read SEC document |
| July 02, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 30,000 | $0.08 | $2,400.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 6 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,411,251 Read SEC document |
| July 01, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 11,000 | $0.09 | $935.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 5 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,441,251 Read SEC document |
| June 28, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.10 | $1,000.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 4 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,452,251 Read SEC document |
| June 25, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.10 | $1,000.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 3 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,462,251 Read SEC document |
| February 04, 2010 Filed Jul 3, 2017 15:14 UTC |
Karloff Kathleen tDirector · CEO/Chairman
|
GrantINVO Bioscience Common Stock | 325,000 | $0.01 | $3,250.00 |
DisclosureSEC source: 0001185185-17-001510 · form5-karloff123110.xml · nonDerivative · entry 2 Karloff Kathleen t · CIK 0001493763 · Director · CEO/Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,960,000 Read SEC document |
| January 06, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 9,222 | $0.18 | $1,659.96 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,472,251 Read SEC document |
| January 05, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.19 | $1,900.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,481,473 Read SEC document |
| December 31, 2009 Filed Jul 25, 2017 13:18 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.20 | $2,000.00 |
DisclosureSEC source: 0001511164-17-000407 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 830,000 Read SEC document |
| May 08, 2009 Filed Jul 3, 2017 15:12 UTC |
Karloff Kathleen tDirector · CEO/Chairman
|
Disposition to issuerINVO Bioscience Common Stock | 240,000 | $0.20 | $48,000.00 |
DisclosureSEC source: 0001185185-17-001508 · form5-karloff123109.xml · nonDerivative · entry 1 Karloff Kathleen t · CIK 0001493763 · Director · CEO/Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,622,159 Read SEC document |
| January 02, 2009 Filed Jul 3, 2017 14:30 UTC |
Bowdring Robert Joseph JrChief Financial Officer
|
GrantINVO Bioscience Common Stock (Restricted) | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-17-001489 · form5-bowdring123109.xml · nonDerivative · entry 1 Bowdring Robert Joseph Jr · CIK 0001664410 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 05, 2008 Filed Jul 25, 2017 13:07 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
GrantINVO Bioscience Common Stock (Restricted) | 24,661,473 | $0.00 | $19,729.18 |
DisclosureSEC source: 0001511164-17-000406 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,661,473 Read SEC document |
| December 05, 2008 Filed Jul 25, 2017 13:07 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
GrantINVO Bioscience Common Stock (Free trading) | 840,000 | $0.00 | $672.00 |
DisclosureSEC source: 0001511164-17-000406 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.